These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23576953)

  • 1. Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines.
    Niclis JC; Pinar A; Haynes JM; Alsanie W; Jenny R; Dottori M; Cram DS
    Front Cell Neurosci; 2013; 7():37. PubMed ID: 23576953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
    Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
    Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of Huntington's disease-affected human embryonic stem cell lines.
    Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
    Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
    Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
    Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
    Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
    Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
    Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
    Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.
    Jacquet L; Neueder A; Földes G; Karagiannis P; Hobbs C; Jolinon N; Mioulane M; Sakai T; Harding SE; Ilic D
    PLoS One; 2015; 10(5):e0126860. PubMed ID: 25993131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
    Lu B; Palacino J
    FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
    Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
    J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances.
    McQuade LR; Balachandran A; Scott HA; Khaira S; Baker MS; Schmidt U
    J Proteome Res; 2014 Dec; 13(12):5648-59. PubMed ID: 25316320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.
    Latoszek E; Czeredys M
    Front Cell Dev Biol; 2021; 9():657337. PubMed ID: 33869222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities.
    Malankhanova T; Suldina L; Grigor'eva E; Medvedev S; Minina J; Morozova K; Kiseleva E; Zakian S; Malakhova A
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33182269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington's disease.
    Park HJ; Han A; Kim JY; Choi J; Bae HS; Cho GB; Shin H; Shin EJ; Lee KI; Kim S; Lee JY; Song J
    NPJ Regen Med; 2022 Jan; 7(1):8. PubMed ID: 35046408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.
    Zhang N; An MC; Montoro D; Ellerby LM
    PLoS Curr; 2010 Oct; 2():RRN1193. PubMed ID: 21037797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal instability during neurogenesis in Huntington's disease.
    Ruzo A; Croft GF; Metzger JJ; Galgoczi S; Gerber LJ; Pellegrini C; Wang H; Fenner M; Tse S; Marks A; Nchako C; Brivanlou AH
    Development; 2018 Jan; 145(2):. PubMed ID: 29378824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
    Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J
    Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
    Geater C; Hernandez S; Thompson L; Mattis VB
    Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.